168 related articles for article (PubMed ID: 38284713)
1. Effect of HPV Oncoprotein on Carbohydrate and Lipid Metabolism in Tumor Cells.
Chen B; Wang Y; Wu Y; Xu T
Curr Cancer Drug Targets; 2024 Jan; ():. PubMed ID: 38284713
[TBL] [Abstract][Full Text] [Related]
2. Advances in molecular mechanism of HPV16 E5 oncoprotein carcinogenesis.
Chen B; Zhao L; Yang R; Xu T
Arch Biochem Biophys; 2023 Sep; 745():109716. PubMed ID: 37553047
[TBL] [Abstract][Full Text] [Related]
3. Metabolic reprogramming in cervical cancer and metabolomics perspectives.
Li B; Sui L
Nutr Metab (Lond); 2021 Oct; 18(1):93. PubMed ID: 34666780
[TBL] [Abstract][Full Text] [Related]
4. Human Papillomavirus-Associated Cancers.
Alhamlan FS; Alfageeh MB; Al Mushait MA; Al-Badawi IA; Al-Ahdal MN
Adv Exp Med Biol; 2021; 1313():1-14. PubMed ID: 34661888
[TBL] [Abstract][Full Text] [Related]
5. HPV-associated cancers: insights into the mechanistic scenario and latest updates.
Mukherjee AG; Ramesh Wanjari U; Valsala Gopalakrishnan A; Jayaraj R; Katturajan R; Kannampuzha S; Murali R; Namachivayam A; Evan Prince S; Vellingiri B; Dey A; Renu K
Med Oncol; 2023 Jun; 40(8):212. PubMed ID: 37358816
[TBL] [Abstract][Full Text] [Related]
6. Human papilloma virus and genitourinary cancers: a narrative review.
Cai T; Di Vico T; Durante J; Tognarelli A; Bartoletti R
Minerva Urol Nefrol; 2018 Dec; 70(6):579-587. PubMed ID: 30160386
[TBL] [Abstract][Full Text] [Related]
7. [Anticipated efficacy of HPV vaccination in prophylaxis against nongenital cancers].
Sehnal B; Vojáčková N; Driák D; Kmoníčková E; Vaňousová D; Maxová K; Neumannová H; Sláma J
Klin Onkol; 2014; 27(4):239-46. PubMed ID: 25115712
[TBL] [Abstract][Full Text] [Related]
8. Metabolic Reprogramming in Cancer: Role of HPV 16 Variants.
Arizmendi-Izazaga A; Navarro-Tito N; Jiménez-Wences H; Mendoza-Catalán MA; Martínez-Carrillo DN; Zacapala-Gómez AE; Olea-Flores M; Dircio-Maldonado R; Torres-Rojas FI; Soto-Flores DG; Illades-Aguiar B; Ortiz-Ortiz J
Pathogens; 2021 Mar; 10(3):. PubMed ID: 33809480
[TBL] [Abstract][Full Text] [Related]
9. A small molecule targeting the interaction between human papillomavirus E7 oncoprotein and cellular phosphatase PTPN14 exerts antitumoral activity in cervical cancer cells.
Bertagnin C; Messa L; Pavan M; Celegato M; Sturlese M; Mercorelli B; Moro S; Loregian A
Cancer Lett; 2023 Sep; 571():216331. PubMed ID: 37532093
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus burden in different cancers in Iran: a systematic assessment.
Jalilvand S; Shoja Z; Hamkar R
Asian Pac J Cancer Prev; 2014; 15(17):7029-35. PubMed ID: 25227786
[TBL] [Abstract][Full Text] [Related]
11. Five-year relative survival for human papillomavirus-associated cancer sites.
Razzaghi H; Saraiya M; Thompson TD; Henley SJ; Viens L; Wilson R
Cancer; 2018 Jan; 124(1):203-211. PubMed ID: 29105738
[TBL] [Abstract][Full Text] [Related]
12. Survival-Associated Metabolic Genes in Human Papillomavirus-Positive Head and Neck Cancers.
Prusinkiewicz MA; Gameiro SF; Ghasemi F; Dodge MJ; Zeng PYF; Maekebay H; Barrett JW; Nichols AC; Mymryk JS
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31968678
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus in the setting of immunodeficiency: Pathogenesis and the emergence of next-generation therapies to reduce the high associated cancer risk.
Hewavisenti RV; Arena J; Ahlenstiel CL; Sasson SC
Front Immunol; 2023; 14():1112513. PubMed ID: 36960048
[TBL] [Abstract][Full Text] [Related]
14. Beyond cervical cancer: burden of other HPV-related cancers among men and women.
Chaturvedi AK
J Adolesc Health; 2010 Apr; 46(4 Suppl):S20-6. PubMed ID: 20307840
[TBL] [Abstract][Full Text] [Related]
15. Transforming human papillomavirus infection and the esophageal transformation zone: prime time for total excision/ablative therapy?
Rajendra S; Sharma P
Dis Esophagus; 2019 Jul; 32(7):. PubMed ID: 31304554
[TBL] [Abstract][Full Text] [Related]
16. Genitoanal human papillomavirus infection and associated neoplasias.
Gross G
Curr Probl Dermatol; 2014; 45():98-122. PubMed ID: 24643181
[TBL] [Abstract][Full Text] [Related]
17. Next generation sequencing and its applications in HPV-associated cancers.
Tuna M; Amos CI
Oncotarget; 2017 Jan; 8(5):8877-8889. PubMed ID: 27784002
[TBL] [Abstract][Full Text] [Related]
18. Targeting of HPV-16+ Epithelial Cancer Cells by TCR Gene Engineered T Cells Directed against E6.
Draper LM; Kwong ML; Gros A; Stevanović S; Tran E; Kerkar S; Raffeld M; Rosenberg SA; Hinrichs CS
Clin Cancer Res; 2015 Oct; 21(19):4431-9. PubMed ID: 26429982
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus (HPV) prevalence and HPV type distribution in cervical, vulvar, and anal cancers in central and eastern Europe.
Škamperle M; Kocjan BJ; Maver PJ; Seme K; Poljak M
Acta Dermatovenerol Alp Pannonica Adriat; 2013; 22(1):1-5. PubMed ID: 23674179
[TBL] [Abstract][Full Text] [Related]
20. HPV: Molecular pathways and targets.
Gupta S; Kumar P; Das BC
Curr Probl Cancer; 2018; 42(2):161-174. PubMed ID: 29706467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
